A new study led by a Tulane University researcher and recently published in the journal, Lancet Infectious Diseases, could change the way doctors treat the common, sexually transmitted parasite, Trichomonas vaginalis.

Joining me today to talk about trichomoniasis and the new study is the lead author, infectious disease epidemiologist at the Tulane University School of Public Health and Tropical Medicine , Dr. Patricia Kissinger.

Show notes: Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomized controlled trial

 

 



Related: 

 

Press Pass Collectibles